Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Combining 3D printing, special effects helps make surgical practice perfect

Practicing complex surgical procedures on cadavers can be expensive. In an article in Journal of Neurosurgery: Pediatrics, researchers outlined an improved method of practice for surgeons by combining 3D printing with special effects.

Thumbnail

Express Scripts likely to lose Anthem, its biggest customer

Pharmacy benefits manager Express Scripts said it will lose Anthem as a client when its current contract expires at the end of 2019, claiming it can’t agree to the price concessions Anthem has been demanding.

Medicaid lost $1 billion in savings to illegal medical cannabis

Cost efficiency is a major concern for any healthcare provider, always searching for a more affordable, effective method of treatment. Medicaid has not been able to cash in the savings after reported having lost out on $1 billion in saving on prescriptions if cannabis were legalized. 

Trimming costs means trimming jobs in healthcare

Healthcare costs have continued to rise above the rate of inflation as more jobs were created in the industry, but as California Healthline reports, trying to cut the former will lead to fewer of the latter.

Thumbnail

Respiratory point-of-care testing reduces length of stay, limits antibiotic use

Respiratory virus infections commonly lead to hospital admissions, costing health systems time and resources. A recent study, published in Lancet Respiratory Medicine, examined how point-of-care testing (POCT) for respiratory infections can reduce unnecessary antibiotic use and length of stay while improving detection and treatment.

Becton Dickinson to acquire CR Bard for $24 billion

Medical equipment giant Becton, Dickinson and Co. (BD) is getting bigger, announcing a $24 billion cash-and-stock deal to acquire CR Bard, including its portfolio in oncology, vascular and surgical products.

$40 million billing scheme results in charges for 26 doctors, pharmacists

California prosecutors charged 26 physicians, pharmacists and business owners in an alleged billing fraud and kickback scheme that collected more than $40 million from insurers by prescribing unnecessary medications or balms which had no medical value. 

Augmented reality helps surgeons, students see a bigger picture

Leica Microsystems, developers of microscopes capable of viewing microstructures and nanostructures, has introduced its augmented reality imaging technologies for surgical microscopes at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting 2017. The GLOW800 supports surgeons in making decisions and teaching students on complex neurosurgical procedures.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.